Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Risk factors for unplanned removal of central venous catheters in hospitalized children with hematological and oncological disorders

View through CrossRef
Background: Central venous catheters (CVCs) have been essential devices for the treatment of children with hematological and oncological disorders. Only few studies investigated the complications and selections of different types of CVCs in these pediatric patients. This study aimed to compare risk factors for unplanned removal of two commonly used CVCs, i.e., peripherally inserted central catheters (PICCs) and tunneled CVCs, and propose better device selection for the patient. Procedure: This retrospective, single center cohort analysis was conducted on pediatric patients with hematological and oncological disorders inserted with either a PICC or a tunneled CVC. Results: Between January 1, 2013, and December 31, 2015, 89 patients inserted with tunneled CVCs (total 21,395 catheter-days) and 84 with PICCs (total 9,177 catheter-days) were followed up until the catheter removal. The median duration of catheterization was 88 days in PICCs and 186 days in tunneled CVCs (p = 1.24×10-9). PICCs at the 3-month cumulative incidence of catheter occlusion (5.2% vs. 0%, p = 4.08×10-3) and total unplanned removal (29.0% vs 7.0%, p = 0.0316) were significantly higher, whereas no significant difference was observed in the cumulative incidence of central line-associated bloodstream infection (11.8% vs. 2.3%, p = 0.664). Multivariable analysis identified younger age (<2 years) (subdistribution hazard ratio [SHR], 2.29; 95% confidence interval [CI], 1.27–4.14) and PICCs (SHR, 2.73; 95% CI, 1.48–5.02) were independent risk factors for unplanned removal. Conclusion: Our results suggest that tunnel CVCs would be a preferred device for children with hematological and oncological disorders requiring long-term, intensive treatment.
Title: Risk factors for unplanned removal of central venous catheters in hospitalized children with hematological and oncological disorders
Description:
Background: Central venous catheters (CVCs) have been essential devices for the treatment of children with hematological and oncological disorders.
Only few studies investigated the complications and selections of different types of CVCs in these pediatric patients.
This study aimed to compare risk factors for unplanned removal of two commonly used CVCs, i.
e.
, peripherally inserted central catheters (PICCs) and tunneled CVCs, and propose better device selection for the patient.
Procedure: This retrospective, single center cohort analysis was conducted on pediatric patients with hematological and oncological disorders inserted with either a PICC or a tunneled CVC.
Results: Between January 1, 2013, and December 31, 2015, 89 patients inserted with tunneled CVCs (total 21,395 catheter-days) and 84 with PICCs (total 9,177 catheter-days) were followed up until the catheter removal.
The median duration of catheterization was 88 days in PICCs and 186 days in tunneled CVCs (p = 1.
24×10-9).
PICCs at the 3-month cumulative incidence of catheter occlusion (5.
2% vs.
0%, p = 4.
08×10-3) and total unplanned removal (29.
0% vs 7.
0%, p = 0.
0316) were significantly higher, whereas no significant difference was observed in the cumulative incidence of central line-associated bloodstream infection (11.
8% vs.
2.
3%, p = 0.
664).
Multivariable analysis identified younger age (<2 years) (subdistribution hazard ratio [SHR], 2.
29; 95% confidence interval [CI], 1.
27–4.
14) and PICCs (SHR, 2.
73; 95% CI, 1.
48–5.
02) were independent risk factors for unplanned removal.
Conclusion: Our results suggest that tunnel CVCs would be a preferred device for children with hematological and oncological disorders requiring long-term, intensive treatment.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Analysis of factors influencing unplanned extubation in children and implementation of nursing strategies (Preprint)
Analysis of factors influencing unplanned extubation in children and implementation of nursing strategies (Preprint)
BACKGROUND Unplanned extubation (UEX) serves as a crucial indicator for monitoring the quality of nursing care and can result in irreversible harm, impactin...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Acute Dialysis Catheters
Acute Dialysis Catheters
Acute dialysis catheters are non‐cuffed, non‐tunnelled catheters used for immediate vascular access. They are primarily used for acute renal failure in bed‐bound patients and for s...
Prospective Study of Incidence and Predictors of Peripheral IV Catheter–Induced Complications
Prospective Study of Incidence and Predictors of Peripheral IV Catheter–Induced Complications
BackgroundPeripheral intravenous catheters (PIVs) are invasive catheters that may endure risks of clinical complications affecting health care outcomes and patient satisfaction. Pa...
Spectrum of benign and malignant hematological diseases diagnosed in Quetta on bone marrow aspiration.
Spectrum of benign and malignant hematological diseases diagnosed in Quetta on bone marrow aspiration.
Objectives: Bone marrow aspiration is a diagnostic test for various hematological disorders. Present study was designed to determine the percentages and frequency of benign and mal...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...

Back to Top